MUC1 and pachyonychia congenita: In support of these results and importantly, analysis of the TCGA and SU2C PC tumor datasets demonstrated that MUC1 significantly correlates with activation of the NFE2L2.V2 signature (Fig. 4E, F) and SLC7A11 and G6PD gene expression (Fig. 4G).